AZN icon

AstraZeneca

1,392 hedge funds and large institutions have $45.2B invested in AstraZeneca in 2025 Q4 according to their latest regulatory filings, with 257 funds opening new positions, 497 increasing their positions, 410 reducing their positions, and 119 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
1,392
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
21
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$597M
Puts
$420M
Net Calls
Net Calls Change

Top Buyers

1 +$420M
2 +$412M
3 +$327M
4
Citigroup
Citigroup
New York
+$204M
5
Barclays
Barclays
United Kingdom
+$180M

Top Sellers

1 -$924M
2 -$831M
3 -$550M
4
Primecap Management
Primecap Management
California
-$258M
5
Citadel Advisors
Citadel Advisors
Florida
-$241M
Name Holding Trade Value Shares
Change
Change in
Stake
CW
1451
CreativeOne Wealth
Kansas
SP
1452
Saranac Partners
LCGC
1453
Legacy Capital Group California
California
PVI
1454
Pine Valley Investments
New Jersey
BBW
1455
Blue Barn Wealth
Utah
GAG
1456
GM Advisory Group
New York
CPRC
1457
Consolidated Portfolio Review Corp
New York
NP
1458
NorthRock Partners
Minnesota
JG
1459
Jain Global
New York
APA
1460
Astoria Portfolio Advisors
New York
AP
1461
Advisors Preferred
Maryland
BAM
1462
Blueshift Asset Management
New Jersey
SA
1463
Sonoma Allocations
California
MFG
1464
MidWestOne Financial Group
Iowa
SB
1465
SIG Brokerage
New York
BFA
1466
Beaumont Financial Advisors
Massachusetts
NEPPG
1467
New England Professional Planning Group
Rhode Island
BCM
1468
Bayesian Capital Management
New York
AO
1469
Advisor OS
Illinois
AGA
1470
Accuvest Global Advisors
Utah
FMWA
1471
Forvis Mazars Wealth Advisors
Missouri
MM
1472
MQS Management
New York
FNBT
1473
FineMark National Bank & Trust
Florida
FFA
1474
Founders Financial Alliance
North Carolina
DCM
1475
Donaldson Capital Management
Indiana